A Study to Investigate the Drug-drug Interactions (DDIs) Between SKLB1028 and Midazolam in Healthy Subjects
Status:
Completed
Trial end date:
2021-07-09
Target enrollment:
Participant gender:
Summary
This is a single-center, open-label phase I clinical study to investigate the effect of
SKLB1028 on the pharmacokinetics of Midazolam and its metabolite 1'-OH-midazolam in healthy
subjects. This study also aims to evaluate the safety and tolerability of SKLB1028 in the
presence of Midazolam.